KRAS and neoplasm: Understanding the molecular mechanism of miRNA-mediated regulation of KRAS by characterizing tumor suppressive miRNAs and oncoproteins that regulate tumor suppressive miRNAs in the KRAS signaling pathway would be beneficial for developing treatments in the clinic.